This federal contract award is for the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, 180 ml, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The $3,058.49 firm fixed-price delivery order has a completion date of November 20, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare systems.
Generated 2/18/25, 1:47 PM